Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations.

Barras, Michael A; Duffull, Stephen B; Atherton, John J; Green, Bruce

Barras, Michael A; Duffull, Stephen B; Atherton, John J; Green, Bruce.

Affiliation

Barras MA; School of Pharmacy, University of Queensland, Brisbane, Australia.

Ther Drug Monit ; 32(4): 482-8, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20592650

Subject(s)

Anticoagulants/administration & dosage; Anticoagulants/therapeutic use; Enoxaparin/administration & dosage; Enoxaparin/therapeutic use; Kidney Diseases/metabolism; Precision Medicine/methods; Algorithms; Drug Monitoring; Humans; Models, Statistical; Obesity/metabolism; Predictive Value of Tests; Prospective Studies; Thromboembolism/drug therapy; Thromboembolism/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enoxaparin / Precision Medicine / Kidney Diseases / Anticoagulants Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ther Drug Monit Year: 2010 Document type: Article Affiliation country: Australia Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google